Logo featuring "BIOVECTRA" in purple text with a blue and yellow abstract design, and the phrase "A part of Agilent" below.
Annual J.P. Morgan Healthcare Conference announcement with molecular structures and DNA helix. Event held in San Francisco, California.

We Are Attending The JP Morgan Healthcare Conference

Meet with BIOVECTRA in San Francisco January 13-16, 2025

BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates, including:

  • Biologics
  • Synthetic small molecules
  • pDNA, mRNA & LNP manufacturing
  • Highly potent APIs
  • Bioreagents
  • Fill/Finish
  • Fermented Small Molecules

Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.

Meet With Us

Schedule a meeting with us and discover how we can support your projects and solve your most complex challenges.

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications